Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1275 of 1467 entries
View as:

S-1 Versus 5-FU Bolus in Metastatic Pancreatic Cancer Patients Previously Treated With Gemcitabine-Based Regimen

Phase: N/A Priority: Normal
NCT ID: NCT00602745 Org: User:
Start: 02/29/08 End: 03/31/10 Due: 03/31/11

A Study to Investigate the Efficacy and Safety of Rilzabrutinib in Adult Participants With Graves' Disease

Phase: N/A Priority: Normal
NCT ID: NCT06984627 Org: User:
Start: 05/30/25 End: 09/23/26 Due: 09/23/27

The Effect of Dupilumab on Lung Inflammation and Related Changes in Airway Volumes Detectable by Functional Respiratory Imaging in Patients With Moderate-severe Asthma

Phase: N/A Priority: Normal
NCT ID: NCT04400318 Org: User:
Start: 06/20/20 End: 08/21/23 Due: 08/21/24

A Phase 1b Trial to Evaluate Safety and Effect of SAR443122 on Immune System in Severe COVID-19

Phase: N/A Priority: Normal
NCT ID: NCT04469621 Org: User:
Start: 07/17/20 End: 10/23/20 Due: 10/23/21

Usability Study of the Commercial Auto-injector Device and the New Auto-injector Device (SYDNEY) in Patients With High or Very High CV Risk With Hypercholesterolemia Not Adequately Controlled With Their Lipid-Modifying Therapy

Phase: N/A Priority: Normal
NCT ID: NCT03415178 Org: User:
Start: 03/29/18 End: 08/09/18 Due: 08/09/19

GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Basal Insulin +/- Sulfonylurea (GETGOAL-L-ASIA)

Phase: N/A Priority: Normal
NCT ID: NCT00866658 Org: User:
Start: 03/31/09 End: 06/30/10 Due: 06/30/11

Evaluation of Weekly Idrabiotaparinux Sodium Versus Oral Adjusted-dose Warfarin to Prevent Stroke and Systemic Thromboembolic Events in Patients With Atrial Fibrillation

Phase: N/A Priority: Normal
NCT ID: NCT00580216 Org: User:
Start: 12/31/07 End: 10/31/10 Due: 10/31/11

Residual Effects of Zolpidem Tartrate Extended Release and Eszopiclone Vs Placebo

Phase: N/A Priority: Normal
NCT ID: NCT00283790 Org: User:
Start: 01/31/06 End: 04/30/06 Due: 04/30/07

Satavaptan for the Prevention of Ascites Recurrence in Patients With Ascites Due to Cirrhosis of the Liver

Phase: N/A Priority: Normal
NCT ID: NCT00366795 Org: User:
Start: 08/31/06 End: 12/31/08 Due: 12/31/09

Efficacy and Safety of Subsequent Cisplatin and Docetaxel in Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00772863 Org: User:
Start: 09/30/03 End: - Due: -

Phase II Study of Oxaliplatine-Paclitaxel in Patients With Metastatic Germ Cell Tumor Refractory to Cisplatin

Phase: N/A Priority: Normal
NCT ID: NCT00611962 Org: User:
Start: 12/31/00 End: 03/31/04 Due: 03/31/05

Effect of Different Doses of SAR110894 on Cognition in Patients With Mild to Moderate Alzheimer's Disease on Donepezil

Phase: N/A Priority: Normal
NCT ID: NCT01266525 Org: User:
Start: 02/28/11 End: 01/31/13 Due: 01/31/14

Phase 1 Safety Testing of SAR405838

Phase: N/A Priority: Normal
NCT ID: NCT01636479 Org: User:
Start: 07/13/12 End: 03/05/18 Due: 03/05/19

Phase I/II Follow-up Study of SAR422459 in Patients With Stargardt's Macular Degeneration

Phase: N/A Priority: Normal
NCT ID: NCT01736592 Org: User:
Start: 12/14/12 End: 08/29/33 Due: 08/29/34

Evaluate Quality of Life in Type 2 Diabetes, Before and After Change to Insuline Glargine

Phase: N/A Priority: Normal
NCT ID: NCT00518427 Org: User:
Start: 10/31/05 End: 03/31/08 Due: 03/31/09

Proof-of-concept Study for SAR441344 (Frexalimab) in Relapsing Multiple Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT04879628 Org: User:
Start: 06/07/21 End: 08/23/27 Due: 08/23/28

Efficacy and Safety of Rimonabant With or Without Hypocaloric Diet in Obese Patients

Phase: N/A Priority: Normal
NCT ID: NCT00481923 Org: User:
Start: 05/31/04 End: 04/30/05 Due: 04/30/06

Open Label Treatment Extension Study With SAR245408 or SAR245409 as a Monotherapy or as a Combination Regimen

Phase: N/A Priority: Normal
NCT ID: NCT01587040 Org: User:
Start: 07/20/12 End: 05/23/18 Due: 05/23/19

Clinical Study Assessing Idrabiotaparinux Sodium Injections Once-weekly in Pulmonary Embolism Therapeutic Approach

Phase: N/A Priority: Normal
NCT ID: NCT00345618 Org: User:
Start: 06/30/06 End: 10/31/10 Due: 10/31/11

Dermacyd PH_DESILSTY_FR (Lactic Acid) - Photo Evaluation - Stay on Frutal

Phase: N/A Priority: Normal
NCT ID: NCT00933257 Org: User:
Start: 06/30/09 End: 07/31/09 Due: 07/31/10

A Phase 1 Study of an Investigational Drug, ALN-AT3SC, in Healthy Volunteers and Hemophilia A or B Patients

Phase: N/A Priority: Normal
NCT ID: NCT02035605 Org: User:
Start: 01/20/14 End: 07/20/17 Due: 07/20/18

A Study to Investigate the Clinical Benefit of Isatuximab in Combination With Bortezomib, Lenalidomide and Dexamethasone in Adults With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant

Phase: N/A Priority: Normal
NCT ID: NCT03319667 Org: User:
Start: 12/07/17 End: 06/30/27 Due: 06/30/28

Efficacy and Safety of Insulin Glargine/Lixisenatide Fixed Combination Versus Insulin Glargine Alone on Top of Metformin in Type 2 Diabetic Patients

Phase: N/A Priority: Normal
NCT ID: NCT01476475 Org: User:
Start: 11/30/11 End: 12/31/12 Due: 12/31/13

European Trial of Dronedarone in Moderate to Severe Congestive Heart Failure

Phase: N/A Priority: Normal
NCT ID: NCT00696631 Org: User:
Start: 06/30/02 End: 08/31/03 Due: 08/31/04

A Study to Test an Oral Medicine, Belumosudil, in Combination With Corticosteroids in Participants at Least 12 Years of Age With Newly Diagnosed Chronic Graft Versus Host Disease.

Phase: N/A Priority: Normal
NCT ID: NCT06143891 Org: User:
Start: 01/23/24 End: 09/29/28 Due: 09/29/29